Iowa

News

August 11, 2016 - Dubuque Telegraph Herald - Hrdlicka: Blaming drugmakers for high health care costs misguided

As we move into the heart of political campaign season, it would be refreshing for candidates to take a realistic look at the value and innovation behind many of the biopharmaceutical drugs that have entered the market.

The target on the back of the biopharmaceutical industry is so large it has united Donald Trump and Hillary Clinton. They have supported a proposal to drastically alter Medicare Part D — the program that covers prescription medicines — by allowing the government to interfere in price negations.

August 11, 2016 - Des Moines Register - Medicare proposals could limit Iowans’ health options

When it comes to a cure for cancer and other life-threatening ailments, researchers are thinking small. Really small.

Scientists at NewLink Genetics, a biopharmaceutical company located in the Iowa State University Research Park, as well as researchers at the Nanovaccine Initiative, coordinated by Iowa State University, are working to develop vaccines and nanovaccines — particles that are 23 times smaller than a red blood cell.

August 06, 2016 - Sioux City Journal - OTHER VOICES: Political leaders should look realistically at pharmaceutical industry

As we move into the heart of political campaign season, it would be refreshing for candidates to take a realistic look at the value and innovation behind many of the biopharmaceutical drugs that have entered the market.

In addition to the medical breakthroughs that are curing Hepatitis C and providing hope to other patients facing serious illness, the biopharmaceutical industry has been an essential driver of job growth, employing some 22,000 people across Iowa. All told, biotech research generates $5.6 billion each year for our state economy. Moreover, the industry's employment growth rate has actually outpaced that of the state's overall job market.

July 28, 2016 - Des Moines Register - Don’t diffuse Iowa’s bioscience boom

McKesson, a pharmaceutical distributor, is about to open an $80 million complex in Clear Lake. The site, which will create 165 jobs, marks a major economic victory for a town with just 3,400 households.

This is just one example of Iowa’s economy benefiting from a vendor relationship with the nation’s bioscience industry. In recent years, the sector has been an essential driver of job growth, employing some 22,000 people across the state. Unfortunately, the success of this vital industry is coming under threat from officials in Washington, D.C.

share this page